Data Foundry

Drug recalls 2015

Zonisamide Capsules — Class II drug recall D-1274-2015

Terminated recall by Wockhardt Usa Inc., reported 2015-07-29, distributed nationwide. CGMP Deviations: Firm did not adequately investigate customer complaints.

Recall numberD-1274-2015
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmWockhardt Usa Inc., Parsippany, NJ, United States
Recall initiated2015-04-22
Classified2015-07-17
Reported by FDA2015-07-29
Terminated2018-05-09
DistributedNationwide (US)
Quantity68,066 bottles
Reason classescgmp
NDC64679-0945-01
Lot numbersLM10763, LM10764, LM10765, LM11142, LM11143, LM11144, LM11255, LM11256, LM11265, LM11542, LM11543, LN10197, LN10198, LN10199, LN10200, LN10202, LN10203, LN10395, LN10396, LN10531, LN10532, LN10533, LN10534, LN10796, LN10942
Expiration dates2015-04-30, 2015-06-30, 2015-07-31, 2015-08-31, 2015-12-31, 2016-01-31, 2016-02-29, 2016-04-30

Product

Zonisamide Capsules, 25 mg Capsules, Packaged in 100 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-0945-01.

Reason for recall

CGMP Deviations: Firm did not adequately investigate customer complaints.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1274-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.